Genmab A/S (GMAB) Fair Value & DCF
Score
GMAB fair value $80.53. Price $51.37. Price is 36% below fair value.
Worked example
Cash-flow value. Starting free cash flow is $8.51 a share. Years 1 to 5 grow at 0.00%. Years 6 to 10 fade that rate in a straight line to 3% terminal growth. The discount rate is 8.70% (beta 0.80). It is beta-adjusted and capped at 12%. The cash-flow value is $123.14 a share.
Earnings value. Next-twelve-months earnings per share of $1.26 times 30.00 is $37.91. The peer group is Biotechnology, 13 companies worth at least $10 billion. Peer median 21.8. Own 10-year median 39.3. The multiple used is the average of the two, kept between 8 and 30, which is 30.00.
Fair value is the average of the two, $80.53. The price is $51.37, which is 36.2% below fair value.